カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別

【英語タイトル】Prostate Cancer Diagnostics Market By Test Type (Preliminary, Confirmatory), By Type (Adenocarcinoma, Interstitial cell carcinoma), By End Use (Hospitals, Outpatient Facilities), By Region And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV181）・商品コード：GRV23NOV181
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

前立腺がん診断薬市場の成長と動向
Grand View Research, Inc.の最新レポートによると、前立腺がん診断薬の世界市場規模は2023年から2030年にかけて年平均成長率6.23%で拡大し、2030年には131億6000万米ドルに達する見込みです。政府の支援策、世界的な疾患有病率の増加、確認診断検査の技術的進歩と相まって前立腺癌の有病率の上昇がこの市場の主な促進要因です。

効果的な診断と治療に焦点を当てた研究を強化するための政府の積極的なイニシアチブの増加は、予測期間中の市場成長を促進する見込みです。例えば、国立がん研究所は、「アフリカ系男性の前立腺がんに関する研究」と題する研究を開始しました。この研究は、アフリカ系アメリカ人男性の前立腺がんに関連する非生物学的および生物学的因子を研究する最大規模の共同研究です。この研究は、National Institute on Minority Health and NCI and Health DisparitiesがProstate Cancer Foundationと共同で立ち上げたもので、2,600万米ドルの資金が提供されました。

ノーフォーク大学およびイースト・アングリア大学の研究者とノリッジ大学病院は、診断から5年以内に治療処置が必要になる可能性が最大8倍低い男性を特定するのに役立つ非侵襲的尿検査を開発しました。このような技術の進歩は、近い将来、市場の可能性にも影響を与えると予想されます。

さらに、カロリンスカ研究所とKTH研究所の研究者らは、空間トランスクリプトミクスに人工知能を使用することで、前立腺がんの早期発見に役立ち、それによって臨床診断と治療が改善されると結論付けています。空間トランスクリプトミクスは、通常、活性遺伝子とその組織型の定量分析を組み合わせた手法であり、効果的な疾患診断に役立ちます。

前立腺がん診断薬市場レポートハイライト

- 2022年の市場シェアは確認検査が最大でした。同セグメントは66.31%で最大市場シェアです。確認検査には、PCA3検査、経直腸超音波検査（TRUS）、患部の生検などが含まれます。

- 最終用途に基づき、市場は病院、外来患者施設、在宅医療、研究・製造に区分されます。2022年には、外来患者施設セグメントが市場を支配しました。外来施設は、認定医の取得と経験により、より快適なコンサルティングと治療システムを革新し、開発しました。

- タイプ別では、腺がん、間質細胞がん、その他に区分されます。2022年には、腺癌セグメントが75.11%の市場シェアで市場を支配しました。腺がんは腺組織にできるがんです。

- 有病率の上昇と診断強化のための政府イニシアチブの高まりにより、北米地域が最大の市場シェアを占めています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の前立腺がん診断薬市場：検査タイプ別予測・動向分析
第5章. 世界の前立腺がん診断薬市場：検査タイプ別予測・動向分析
第6章. 世界の前立腺がん診断薬市場：最終用途別予測・動向分析
第7章. 世界の前立腺がん診断薬市場：地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. Type
1.1.3. End-user
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Snapshot
Chapter 3. Prostate Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing prevalence of prostate cancer
3.3.1.2. Large presence of geriatric population
3.3.2. Market restraint analysis
3.3.2.1. Online Consulting and Treatment
3.4. Prostate Cancer Diagnostics Market: Business Analysis Tools
3.4.1. Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Global Prostate Cancer Diagnostics: Test Type Estimates & Trend Analysis
4.1. Global prostate cancer diagnostics market, test type movement analysis
4.2. Preliminary tests
4.2.1. Preliminary tests for prostate cancer diagnostics market, 2018 – 2030 (USD Million)
4.2.2. PSA tests
4.2.2.1. PSA tests market, 2018 – 2030 (USD Million)
4.2.2.2. Free PSA tests market, 2018 – 2030 (USD Million)
4.2.2.3. Total PSA tests market, 2018 – 2030 (USD Million)
4.2.3. Other preliminary tests
4.2.3.1. Other preliminary tests for prostate cancer diagnostics market, 2018 – 2030 (USD Million)
4.3. Confirmatory tests
4.3.1. Confirmatory tests for prostate cancer diagnostics market, 2018 – 2030 (USD Million)
4.3.2. Pca3 tests
4.3.2.1. Pca3 tests market, 2018 – 2030 (USD Million)
4.3.2.2. Trans-rectal ultrasound market, 2018 – 2030 (USD Million)
4.3.2.3. Biopsy tests market, 2018 – 2030 (USD Million)
Chapter 5. Global prostate cancer diagnostics: Type estimates & trend analysis
5.1. Global prostate cancer diagnostics market, type movement analysis
5.2. Adenocarcinoma
5.2.1. Adenocarcinoma market, 2018 – 2030 (USD Million)
5.3. Interstitial cell carcinoma
5.3.1. Interstitial cell carcinoma market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Others market, 2018 – 2030 (USD Million)
Chapter 6. Global prostate cancer diagnostics: end-use Estimates & Trend Analysis
6.1. Global prostate cancer diagnostics market, end-use movement analysis
6.2. Hospitals
6.2.1. Hospitals market, 2018 – 2030 (USD Million)
6.3. Outpatient facilities
6.3.1. Outpatient facilities market, 2018 – 2030 (USD Million)
6.4. Home care
6.4.1. Home care market, 2018 – 2030 (USD Million)
6.5. Research & manufacturing
6.5.1. Research & manufacturing market, 2018 – 2030 (USD Million)
Chapter 7. Prostate cancer diagnostics market: Regional Estimates & Trend Analysis
7.1. Prostate cancer diagnostics market, regional movement analysis
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key country dynamics
7.2.3.2. Target disease prevalence
7.2.3.3. Competitive scenario
7.2.3.4. Regulatory framework
7.2.3.5. U.S. prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key country dynamics
7.2.4.2. Target disease prevalence
7.2.4.3. Competitive scenario
7.2.4.4. Regulatory framework
7.2.4.5. Canada prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key country dynamics
7.3.3.2. Target disease prevalence
7.3.3.3. Competitive scenario
7.3.3.4. Regulatory framework
7.3.3.5. UK prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key country dynamics
7.3.4.2. Target disease prevalence
7.3.4.3. Competitive scenario
7.3.4.4. Regulatory framework
7.3.4.5. Germany prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.5. France
7.3.5.1. Key country dynamics
7.3.5.2. Target disease prevalence
7.3.5.3. Competitive scenario
7.3.5.4. Regulatory framework
7.3.5.5. France prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key country dynamics
7.3.6.2. Target disease prevalence
7.3.6.3. Competitive scenario
7.3.6.4. Regulatory framework
7.3.6.5. Italy prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key country dynamics
7.3.7.2. Target disease prevalence
7.3.7.3. Competitive scenario
7.3.7.4. Regulatory framework
7.3.7.5. Spain prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key country dynamics
7.3.8.2. Target disease prevalence
7.3.8.3. Competitive scenario
7.3.8.4. Regulatory framework
7.3.8.5. Denmark prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key country dynamics
7.3.9.2. Target disease prevalence
7.3.9.3. Competitive scenario
7.3.9.4. Regulatory framework
7.3.9.5. Sweden prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key country dynamics
7.3.10.2. Target disease prevalence
7.3.10.3. Competitive scenario
7.3.10.4. Regulatory framework
7.3.10.5. Norway prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key country dynamics
7.4.3.2. Target disease prevalence
7.4.3.3. Competitive scenario
7.4.3.4. Regulatory framework
7.4.3.5. Japan prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4.4. China
7.4.4.1. Key country dynamics
7.4.4.2. Target disease prevalence
7.4.4.3. Competitive scenario
7.4.4.4. Regulatory framework
7.4.4.5. China prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4.5. India
7.4.5.1. Key country dynamics
7.4.5.2. Target disease prevalence
7.4.5.3. Competitive scenario
7.4.5.4. Regulatory framework
7.4.5.5. India prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key country dynamics
7.4.6.2. Target disease prevalence
7.4.6.3. Competitive scenario
7.4.6.4. Regulatory framework
7.4.6.5. Australia prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key country dynamics
7.4.7.2. Target disease prevalence
7.4.7.3. Competitive scenario
7.4.7.4. Regulatory framework
7.4.7.5. Thailand prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key country dynamics
7.4.8.2. Target disease prevalence
7.4.8.3. Competitive scenario
7.4.8.4. Regulatory framework
7.4.8.5. South Korea prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key country dynamics
7.5.3.2. Target disease prevalence
7.5.3.3. Competitive scenario
7.5.3.4. Regulatory framework
7.5.3.5. Brazil prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key country dynamics
7.5.4.2. Target disease prevalence
7.5.4.3. Competitive scenario
7.5.4.4. Regulatory framework
7.5.4.5. Mexico prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key country dynamics
7.5.5.2. Target disease prevalence
7.5.5.3. Competitive scenario
7.5.5.4. Regulatory framework
7.5.5.5. Argentina prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key country dynamics
7.6.3.2. Target disease prevalence
7.6.3.3. Competitive scenario
7.6.3.4. Regulatory framework
7.6.3.5. South Africa prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key country dynamics
7.6.4.2. Target disease prevalence
7.6.4.3. Competitive scenario
7.6.4.4. Regulatory framework
7.6.4.5. Saudi Arabia prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key country dynamics
7.6.5.2. Target disease prevalence
7.6.5.3. Competitive scenario
7.6.5.4. Regulatory framework
7.6.5.5. UAE prostate cancer diagnostics market, 2018 – 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key country dynamics
7.6.6.2. Target disease prevalence
7.6.6.3. Competitive scenario
7.6.6.4. Regulatory framework
7.6.6.5. Kuwait prostate cancer diagnostics market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant’s overview
8.2. Financial performance
8.3. Participant categorization
8.3.1. Market leaders
8.3.2. Prostate cancer diagnostics market share analysis, 2022
8.3.3. Company Profiles
8.3.3.1. MDXHEALTH
8.3.3.2. SIGNATURES
8.3.3.3. GENOMIC HEALTH
8.3.3.4. ABBOTT
8.3.3.5. OPKO HEALTH, INC.
8.3.3.6. Oxford Nanopore Technologies plc.
8.3.3.7. SIEMENS HEALTHCARE GMBH
8.3.3.8. CD Genomics
8.3.3.9. DIASORIN S.P.A.
8.3.3.10. BIOMÉRIEUX SA Overview
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Product/Service Launch
8.3.4.5. Partnerships
8.3.4.6. Others

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global prostate cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 4 Global prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 5 Global prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 Global prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America prostate cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 8 North America prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 9 North America prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 10 North America prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 12 U.S. prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 13 U.S. prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 14 Canada prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 15 Canada prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 16 Canada prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 17 Europe prostate cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 18 Europe prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 19 Europe prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 20 Europe prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 21 U.K. prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 22 U.K. prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 23 U.K. prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 24 Germany prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 25 Germany prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 26 Germany prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 27 France prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 28 France prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 France prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 30 Italy prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 31 Italy prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 32 Italy prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 33 Spain prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 34 Spain prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 35 Spain prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 36 Denmark prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 37 Denmark prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 38 Denmark prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 39 Sweden prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 40 Sweden prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 41 Sweden prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 42 Norway prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 43 Norway prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 44 Norway prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 45 Asia-Pacific prostate cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 46 Asia-Pacific prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 47 Asia-Pacific prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 48 Asia-Pacific prostate cancer diagnostics market, by end Use, 2018 - 2030 (USD Million)
Table 49 Japan prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 50 Japan prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 51 Japan prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 52 China prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 53 China prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 54 China prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 55 India prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 56 India prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 57 India prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 58 Australia prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 59 Australia prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 60 Australia prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 61 Thailand prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 62 Thailand prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 63 Thailand prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 64 South Korea prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 65 South Korea prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 66 South Korea prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 67 Latin America prostate cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 69 Latin America prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 70 Latin America prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 71 Brazil prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 72 Brazil prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 73 Brazil prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 74 Mexico prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 75 Mexico prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 76 Mexico prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 77 Argentina prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 78 Argentina prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 79 Argentina prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 80 MEA prostate cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 81 MEA prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 82 MEA prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 83 MEA prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 84 South Africa prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 85 South Africa prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 86 South Africa prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 90 UAE prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 91 UAE prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 92 UAE prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 93 Kuwait prostate cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 94 Kuwait prostate cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 95 Kuwait prostate cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Asia-Pacific
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Prostate Cancer Diagnostics Market: Market Outlook
Fig. 14 Prostate Cancer Diagnostics Market Competitive Insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Prostate Cancer Diagnostics Market Driver Impact
Fig. 19 Prostate Cancer Diagnostics Market Restraint Impact
Fig. 20 Penetration & growth prospect mapping for process, 2022
Fig. 21 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 22 Porter’s Five Forces Analysis
Fig. 23 Global prostate cancer diagnostic market: Test type outlook key takeaways
Fig. 24 Prostate cancer diagnostic market: Test type movement analysis
Fig. 25 Global prostate cancer diagnostic market: Type outlook key takeaways
Fig. 26 Prostate cancer diagnostic market: Type movement analysis
Fig. 27 Global prostate cancer diagnostic market: End-use outlook key takeaways
Fig. 28 Prostate cancer diagnostic market: End-use movement analysis
Fig. 29 Global prostate cancer diagnostic market: Region outlook key takeaways
Fig. 30 Prostate cancer diagnostic market: Region movement analysis
Fig. 31 North America prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 32 U.S prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 33 Canada prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 34 Europe prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 35 Germany prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 36 France prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 37 U.K. prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 38 Italy prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 39 Spain prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 40 Denmark prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 41 Sweden prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 42 Norway prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 44 Japan prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 45 China prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 46 India prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 47 Australia prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 48 South Korea prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 49 Thailand prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 50 Latin America prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 51 Brazil prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 52 Mexico prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 53 Argentina prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 54 Middle East & Africa prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 55 South Africa prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 57 UAE prostate cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 58 Kuwait prostate cancer diagnostic market, 2018 - 2030 (USD Million)

★調査レポート[世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別] (コード：GRV23NOV181)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の前立腺がん診断市場2024-2030：検査タイプ別（予備検査、確認検査）、種類別（腺がん、間質細胞がん、その他）、エンドユーザー別、地域別
  • 世界のロボット支援内視鏡市場（2023-2030）：用途別（病院、外来施設）、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）
  • 世界の体外大腸がんスクリーニング検査市場（2023-2030）：検査種類別（便潜血検査、バイオマーカー検査、CRC DNAスクリーニング検査）、地域別
  • 世界の新生児スクリーニング市場（2023-2030）：技術別（タンデム質量分析、パルスオキシメトリ）、検査種類別、製品別（装置、試薬）、地域別
  • 世界の手動車椅子市場（2023-2030）：カテゴリー別（成人、小児）、エンドユーザー別（病院、外来施設、在宅ケア）、地域別
  • 世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別
  • 世界の使い捨て内視鏡市場2024-2030：種類別（腹腔鏡、関節鏡）、エンドユーザー別（病院、外来施設）、地域別
  • 世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別
  • 世界の医薬品無菌性試験市場（2023-2030）：製品種類別（装置、サービス）、種類別（アウトソーシング、インハウス）、検査種類別、サンプル別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆